Merck’s first-quarter earnings beat estimates, even as COVID-19 treatment sales plummet By: MarketWatch April 27, 2023 at 11:31 AM EDT Sales of cancer drug Keytruda and HPV vaccine Gardasil helped boost pharmaceutical giant’s results. Read More >> Related Stocks: Merck & Co Prometheus Biosciences Inc
